1 Market Overview

1.1 Product Overview and Scope of CAR T-Cell Therapy

1.2 Market Estimation Caveats and Base Year

1.3 Classification of CAR T-Cell Therapy by Type

1.3.1 Overview: Global CAR T-Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029

1.3.2 Global CAR T-Cell Therapy Consumption Value Market Share by Type in 2022

1.3.3 CD19 - Targeted

1.3.4 BCMA - Targeted

1.4 Global CAR T-Cell Therapy Market by Application

1.4.1 Overview: Global CAR T-Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029

1.4.2 Lymphoma

1.4.3 Multiple Myeloma

1.5 Global CAR T-Cell Therapy Market Size & Forecast

1.6 Global CAR T-Cell Therapy Market Size and Forecast by Region

1.6.1 Global CAR T-Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029

1.6.2 Global CAR T-Cell Therapy Market Size by Region, (2018-2029)

1.6.3 North America CAR T-Cell Therapy Market Size and Prospect (2018-2029)

1.6.4 Europe CAR T-Cell Therapy Market Size and Prospect (2018-2029)

1.6.5 Asia-Pacific CAR T-Cell Therapy Market Size and Prospect (2018-2029)

1.6.6 South America CAR T-Cell Therapy Market Size and Prospect (2018-2029)

1.6.7 Middle East and Africa CAR T-Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles

2.1 Novartis

2.1.1 Novartis Details

2.1.2 Novartis Major Business

2.1.3 Novartis CAR T-Cell Therapy Product and Solutions

2.1.4 Novartis CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 Novartis Recent Developments and Future Plans

2.2 Gilead Sciences

2.2.1 Gilead Sciences Details

2.2.2 Gilead Sciences Major Business

2.2.3 Gilead Sciences CAR T-Cell Therapy Product and Solutions

2.2.4 Gilead Sciences CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Gilead Sciences Recent Developments and Future Plans

2.3 Bristol-Myers Squibb

2.3.1 Bristol-Myers Squibb Details

2.3.2 Bristol-Myers Squibb Major Business

2.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Product and Solutions

2.3.4 Bristol-Myers Squibb CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.4 J & J

2.4.1 J & J Details

2.4.2 J & J Major Business

2.4.3 J & J CAR T-Cell Therapy Product and Solutions

2.4.4 J & J CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 J & J Recent Developments and Future Plans

2.5 JW Therapeutics

2.5.1 JW Therapeutics Details

2.5.2 JW Therapeutics Major Business

2.5.3 JW Therapeutics CAR T-Cell Therapy Product and Solutions

2.5.4 JW Therapeutics CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 JW Therapeutics Recent Developments and Future Plans

2.6 FOSUNKite

2.6.1 FOSUNKite Details

2.6.2 FOSUNKite Major Business

2.6.3 FOSUNKite CAR T-Cell Therapy Product and Solutions

2.6.4 FOSUNKite CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 FOSUNKite Recent Developments and Future Plans

2.7 CARsgen Therapeutics (Pipeline)

2.7.1 CARsgen Therapeutics (Pipeline) Details

2.7.2 CARsgen Therapeutics (Pipeline) Major Business

2.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product and Solutions

2.7.4 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans

2.8 Autolus Therapeutics(Pipeline)

2.8.1 Autolus Therapeutics(Pipeline) Details

2.8.2 Autolus Therapeutics(Pipeline) Major Business

2.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions

2.8.4 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 Autolus Therapeutics(Pipeline) Recent Developments and Future Plans

2.9 Sorrento Therapeutics(Pipeline)

2.9.1 Sorrento Therapeutics(Pipeline) Details

2.9.2 Sorrento Therapeutics(Pipeline) Major Business

2.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions

2.9.4 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 Sorrento Therapeutics(Pipeline) Recent Developments and Future Plans

2.10 Mustang Bio(Pipeline)

2.10.1 Mustang Bio(Pipeline) Details

2.10.2 Mustang Bio(Pipeline) Major Business

2.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Product and Solutions

2.10.4 Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 Mustang Bio(Pipeline) Recent Developments and Future Plans

2.11 Bluebird Bio(Pipeline)

2.11.1 Bluebird Bio(Pipeline) Details

2.11.2 Bluebird Bio(Pipeline) Major Business

2.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Product and Solutions

2.11.4 Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 Bluebird Bio(Pipeline) Recent Developments and Future Plans

2.12 Cellectis(Pipeline)

2.12.1 Cellectis(Pipeline) Details

2.12.2 Cellectis(Pipeline) Major Business

2.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Product and Solutions

2.12.4 Cellectis(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 Cellectis(Pipeline) Recent Developments and Future Plans

2.13 Allogene Therapeutics(Pipeline)

2.13.1 Allogene Therapeutics(Pipeline) Details

2.13.2 Allogene Therapeutics(Pipeline) Major Business

2.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions

2.13.4 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 Allogene Therapeutics(Pipeline) Recent Developments and Future Plans

2.14 Celyad(Pipeline)

2.14.1 Celyad(Pipeline) Details

2.14.2 Celyad(Pipeline) Major Business

2.14.3 Celyad(Pipeline) CAR T-Cell Therapy Product and Solutions

2.14.4 Celyad(Pipeline) CAR T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)

2.14.5 Celyad(Pipeline) Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global CAR T-Cell Therapy Revenue and Share by Players (2018-2023)

3.2 Market Share Analysis (2022)

3.2.1 Market Share of CAR T-Cell Therapy by Company Revenue

3.2.2 Top 3 CAR T-Cell Therapy Players Market Share in 2022

3.2.3 Top 6 CAR T-Cell Therapy Players Market Share in 2022

3.3 CAR T-Cell Therapy Market: Overall Company Footprint Analysis

3.3.1 CAR T-Cell Therapy Market: Region Footprint

3.3.2 CAR T-Cell Therapy Market: Company Product Type Footprint

3.3.3 CAR T-Cell Therapy Market: Company Product Application Footprint

3.4 New Market Entrants and Barriers to Market Entry

3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global CAR T-Cell Therapy Consumption Value and Market Share by Type (2018-2023)

4.2 Global CAR T-Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

5.1 Global CAR T-Cell Therapy Consumption Value Market Share by Application (2018-2023)

5.2 Global CAR T-Cell Therapy Market Forecast by Application (2024-2029)

6 North America

6.1 North America CAR T-Cell Therapy Consumption Value by Type (2018-2029)

6.2 North America CAR T-Cell Therapy Consumption Value by Application (2018-2029)

6.3 North America CAR T-Cell Therapy Market Size by Country

6.3.1 North America CAR T-Cell Therapy Consumption Value by Country (2018-2029)

6.3.2 United States CAR T-Cell Therapy Market Size and Forecast (2018-2029)

6.3.3 Canada CAR T-Cell Therapy Market Size and Forecast (2018-2029)

6.3.4 Mexico CAR T-Cell Therapy Market Size and Forecast (2018-2029)

7 Europe

7.1 Europe CAR T-Cell Therapy Consumption Value by Type (2018-2029)

7.2 Europe CAR T-Cell Therapy Consumption Value by Application (2018-2029)

7.3 Europe CAR T-Cell Therapy Market Size by Country

7.3.1 Europe CAR T-Cell Therapy Consumption Value by Country (2018-2029)

7.3.2 Germany CAR T-Cell Therapy Market Size and Forecast (2018-2029)

7.3.3 France CAR T-Cell Therapy Market Size and Forecast (2018-2029)

7.3.4 United Kingdom CAR T-Cell Therapy Market Size and Forecast (2018-2029)

7.3.5 Russia CAR T-Cell Therapy Market Size and Forecast (2018-2029)

7.3.6 Italy CAR T-Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific

8.1 Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2018-2029)

8.2 Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2018-2029)

8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Region

8.3.1 Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2018-2029)

8.3.2 China CAR T-Cell Therapy Market Size and Forecast (2018-2029)

8.3.3 Japan CAR T-Cell Therapy Market Size and Forecast (2018-2029)

8.3.4 South Korea CAR T-Cell Therapy Market Size and Forecast (2018-2029)

8.3.5 India CAR T-Cell Therapy Market Size and Forecast (2018-2029)

8.3.6 Southeast Asia CAR T-Cell Therapy Market Size and Forecast (2018-2029)

8.3.7 Australia CAR T-Cell Therapy Market Size and Forecast (2018-2029)

9 South America

9.1 South America CAR T-Cell Therapy Consumption Value by Type (2018-2029)

9.2 South America CAR T-Cell Therapy Consumption Value by Application (2018-2029)

9.3 South America CAR T-Cell Therapy Market Size by Country

9.3.1 South America CAR T-Cell Therapy Consumption Value by Country (2018-2029)

9.3.2 Brazil CAR T-Cell Therapy Market Size and Forecast (2018-2029)

9.3.3 Argentina CAR T-Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa

10.1 Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2018-2029)

10.2 Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2018-2029)

10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Country

10.3.1 Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2018-2029)

10.3.2 Turkey CAR T-Cell Therapy Market Size and Forecast (2018-2029)

10.3.3 Saudi Arabia CAR T-Cell Therapy Market Size and Forecast (2018-2029)

10.3.4 UAE CAR T-Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics

11.1 CAR T-Cell Therapy Market Drivers

11.2 CAR T-Cell Therapy Market Restraints

11.3 CAR T-Cell Therapy Trends Analysis

11.4 Porters Five Forces Analysis

11.4.1 Threat of New Entrants

11.4.2 Bargaining Power of Suppliers

11.4.3 Bargaining Power of Buyers

11.4.4 Threat of Substitutes

11.4.5 Competitive Rivalry

11.5 Influence of COVID-19 and Russia-Ukraine War

11.5.1 Influence of COVID-19

11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

12.1 CAR T-Cell Therapy Industry Chain

12.2 CAR T-Cell Therapy Upstream Analysis

12.3 CAR T-Cell Therapy Midstream Analysis

12.4 CAR T-Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global CAR T-Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. Global CAR T-Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)

Table 4. Global CAR T-Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)

Table 5. Novartis Company Information, Head Office, and Major Competitors

Table 6. Novartis Major Business

Table 7. Novartis CAR T-Cell Therapy Product and Solutions

Table 8. Novartis CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 9. Novartis Recent Developments and Future Plans

Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors

Table 11. Gilead Sciences Major Business

Table 12. Gilead Sciences CAR T-Cell Therapy Product and Solutions

Table 13. Gilead Sciences CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 14. Gilead Sciences Recent Developments and Future Plans

Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors

Table 16. Bristol-Myers Squibb Major Business

Table 17. Bristol-Myers Squibb CAR T-Cell Therapy Product and Solutions

Table 18. Bristol-Myers Squibb CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 19. Bristol-Myers Squibb Recent Developments and Future Plans

Table 20. J & J Company Information, Head Office, and Major Competitors

Table 21. J & J Major Business

Table 22. J & J CAR T-Cell Therapy Product and Solutions

Table 23. J & J CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 24. J & J Recent Developments and Future Plans

Table 25. JW Therapeutics Company Information, Head Office, and Major Competitors

Table 26. JW Therapeutics Major Business

Table 27. JW Therapeutics CAR T-Cell Therapy Product and Solutions

Table 28. JW Therapeutics CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 29. JW Therapeutics Recent Developments and Future Plans

Table 30. FOSUNKite Company Information, Head Office, and Major Competitors

Table 31. FOSUNKite Major Business

Table 32. FOSUNKite CAR T-Cell Therapy Product and Solutions

Table 33. FOSUNKite CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 34. FOSUNKite Recent Developments and Future Plans

Table 35. CARsgen Therapeutics (Pipeline) Company Information, Head Office, and Major Competitors

Table 36. CARsgen Therapeutics (Pipeline) Major Business

Table 37. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product and Solutions

Table 38. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 39. CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans

Table 40. Autolus Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors

Table 41. Autolus Therapeutics(Pipeline) Major Business

Table 42. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions

Table 43. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 44. Autolus Therapeutics(Pipeline) Recent Developments and Future Plans

Table 45. Sorrento Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors

Table 46. Sorrento Therapeutics(Pipeline) Major Business

Table 47. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions

Table 48. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 49. Sorrento Therapeutics(Pipeline) Recent Developments and Future Plans

Table 50. Mustang Bio(Pipeline) Company Information, Head Office, and Major Competitors

Table 51. Mustang Bio(Pipeline) Major Business

Table 52. Mustang Bio(Pipeline) CAR T-Cell Therapy Product and Solutions

Table 53. Mustang Bio(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 54. Mustang Bio(Pipeline) Recent Developments and Future Plans

Table 55. Bluebird Bio(Pipeline) Company Information, Head Office, and Major Competitors

Table 56. Bluebird Bio(Pipeline) Major Business

Table 57. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product and Solutions

Table 58. Bluebird Bio(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 59. Bluebird Bio(Pipeline) Recent Developments and Future Plans

Table 60. Cellectis(Pipeline) Company Information, Head Office, and Major Competitors

Table 61. Cellectis(Pipeline) Major Business

Table 62. Cellectis(Pipeline) CAR T-Cell Therapy Product and Solutions

Table 63. Cellectis(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 64. Cellectis(Pipeline) Recent Developments and Future Plans

Table 65. Allogene Therapeutics(Pipeline) Company Information, Head Office, and Major Competitors

Table 66. Allogene Therapeutics(Pipeline) Major Business

Table 67. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product and Solutions

Table 68. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 69. Allogene Therapeutics(Pipeline) Recent Developments and Future Plans

Table 70. Celyad(Pipeline) Company Information, Head Office, and Major Competitors

Table 71. Celyad(Pipeline) Major Business

Table 72. Celyad(Pipeline) CAR T-Cell Therapy Product and Solutions

Table 73. Celyad(Pipeline) CAR T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 74. Celyad(Pipeline) Recent Developments and Future Plans

Table 75. Global CAR T-Cell Therapy Revenue (USD Million) by Players (2018-2023)

Table 76. Global CAR T-Cell Therapy Revenue Share by Players (2018-2023)

Table 77. Breakdown of CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)

Table 78. Market Position of Players in CAR T-Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022

Table 79. Head Office of Key CAR T-Cell Therapy Players

Table 80. CAR T-Cell Therapy Market: Company Product Type Footprint

Table 81. CAR T-Cell Therapy Market: Company Product Application Footprint

Table 82. CAR T-Cell Therapy New Market Entrants and Barriers to Market Entry

Table 83. CAR T-Cell Therapy Mergers, Acquisition, Agreements, and Collaborations

Table 84. Global CAR T-Cell Therapy Consumption Value (USD Million) by Type (2018-2023)

Table 85. Global CAR T-Cell Therapy Consumption Value Share by Type (2018-2023)

Table 86. Global CAR T-Cell Therapy Consumption Value Forecast by Type (2024-2029)

Table 87. Global CAR T-Cell Therapy Consumption Value by Application (2018-2023)

Table 88. Global CAR T-Cell Therapy Consumption Value Forecast by Application (2024-2029)

Table 89. North America CAR T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 90. North America CAR T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 91. North America CAR T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 92. North America CAR T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 93. North America CAR T-Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 94. North America CAR T-Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 95. Europe CAR T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 96. Europe CAR T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 97. Europe CAR T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 98. Europe CAR T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 99. Europe CAR T-Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 100. Europe CAR T-Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 101. Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 102. Asia-Pacific CAR T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 103. Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 104. Asia-Pacific CAR T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 105. Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)

Table 106. Asia-Pacific CAR T-Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)

Table 107. South America CAR T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 108. South America CAR T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 109. South America CAR T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 110. South America CAR T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 111. South America CAR T-Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 112. South America CAR T-Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 113. Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)

Table 114. Middle East & Africa CAR T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)

Table 115. Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)

Table 116. Middle East & Africa CAR T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)

Table 117. Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)

Table 118. Middle East & Africa CAR T-Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)

Table 119. CAR T-Cell Therapy Raw Material

Table 120. Key Suppliers of CAR T-Cell Therapy Raw Materials

List of Figures

Figure 1. CAR T-Cell Therapy Picture

Figure 2. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global CAR T-Cell Therapy Consumption Value Market Share by Type in 2022

Figure 4. CD19 - Targeted

Figure 5. BCMA - Targeted

Figure 6. Global CAR T-Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 7. CAR T-Cell Therapy Consumption Value Market Share by Application in 2022

Figure 8. Lymphoma Picture

Figure 9. Multiple Myeloma Picture

Figure 10. Global CAR T-Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 11. Global CAR T-Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 12. Global Market CAR T-Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)

Figure 13. Global CAR T-Cell Therapy Consumption Value Market Share by Region (2018-2029)

Figure 14. Global CAR T-Cell Therapy Consumption Value Market Share by Region in 2022

Figure 15. North America CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 16. Europe CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 17. Asia-Pacific CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 18. South America CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 19. Middle East and Africa CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 20. Global CAR T-Cell Therapy Revenue Share by Players in 2022

Figure 21. CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022

Figure 22. Global Top 3 Players CAR T-Cell Therapy Market Share in 2022

Figure 23. Global Top 6 Players CAR T-Cell Therapy Market Share in 2022

Figure 24. Global CAR T-Cell Therapy Consumption Value Share by Type (2018-2023)

Figure 25. Global CAR T-Cell Therapy Market Share Forecast by Type (2024-2029)

Figure 26. Global CAR T-Cell Therapy Consumption Value Share by Application (2018-2023)

Figure 27. Global CAR T-Cell Therapy Market Share Forecast by Application (2024-2029)

Figure 28. North America CAR T-Cell Therapy Consumption Value Market Share by Type (2018-2029)

Figure 29. North America CAR T-Cell Therapy Consumption Value Market Share by Application (2018-2029)

Figure 30. North America CAR T-Cell Therapy Consumption Value Market Share by Country (2018-2029)

Figure 31. United States CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 32. Canada CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 33. Mexico CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 34. Europe CAR T-Cell Therapy Consumption Value Market Share by Type (2018-2029)

Figure 35. Europe CAR T-Cell Therapy Consumption Value Market Share by Application (2018-2029)

Figure 36. Europe CAR T-Cell Therapy Consumption Value Market Share by Country (2018-2029)

Figure 37. Germany CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 38. France CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 39. United Kingdom CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 40. Russia CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 41. Italy CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 42. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Type (2018-2029)

Figure 43. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Application (2018-2029)

Figure 44. Asia-Pacific CAR T-Cell Therapy Consumption Value Market Share by Region (2018-2029)

Figure 45. China CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 46. Japan CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 47. South Korea CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 48. India CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 49. Southeast Asia CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 50. Australia CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 51. South America CAR T-Cell Therapy Consumption Value Market Share by Type (2018-2029)

Figure 52. South America CAR T-Cell Therapy Consumption Value Market Share by Application (2018-2029)

Figure 53. South America CAR T-Cell Therapy Consumption Value Market Share by Country (2018-2029)

Figure 54. Brazil CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 55. Argentina CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 56. Middle East and Africa CAR T-Cell Therapy Consumption Value Market Share by Type (2018-2029)

Figure 57. Middle East and Africa CAR T-Cell Therapy Consumption Value Market Share by Application (2018-2029)

Figure 58. Middle East and Africa CAR T-Cell Therapy Consumption Value Market Share by Country (2018-2029)

Figure 59. Turkey CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 60. Saudi Arabia CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 61. UAE CAR T-Cell Therapy Consumption Value (2018-2029) & (USD Million)

Figure 62. CAR T-Cell Therapy Market Drivers

Figure 63. CAR T-Cell Therapy Market Restraints

Figure 64. CAR T-Cell Therapy Market Trends

Figure 65. Porters Five Forces Analysis

Figure 66. Manufacturing Cost Structure Analysis of CAR T-Cell Therapy in 2022

Figure 67. Manufacturing Process Analysis of CAR T-Cell Therapy

Figure 68. CAR T-Cell Therapy Industrial Chain

Figure 69. Methodology

Figure 70. Research Process and Data Source